HER2Know.com

HER2Know.com is a clinical education portal supporting the pathology community to evolve with advancements in HER2 IHC assessment in breast cancer.

Created by a faculty of leading breast pathologists, HER2Know features a wide array of peer-to-peer resources to assist with the interpretation and reporting of discrete HER2 IHC scores. For US healthcare professionals only. HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

©2022 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-8201a-1414 08/22